|
|||||||
Organ
of the
|
GD Society for Dermopharmacy |
||||||
GD News Risk Assessment and Regulatory Affairs New GD Department Set to Work with Ambitious Projects Following the departments Dermatopharmacology, Dermatotherapy, Dermocosmetics and Extemporaneous Preparations already established some time ago, the recently founded GD department Risk Assessment and Regulatory Affairs has also taken up its work. Its tasks will comprise safety-toxicological and regulatory questions on dermatics, medicinal products, cosmetics and chemicals. First definite project of the group is the drawing up of a statement and organization of a symposium on Registration, Evaluation and Authorization of Chemicals (REACH), the central part of the new European chemical legislation. In the course of the constituting meeting of the department in Cologne
on 7 October 2005 the pharmacist Dr. Jürgen Regenold, Badenweiler
was elected department head. Regenold is considered to be an expert in
the field of drug authorization; he represents thus an essential section
of the future department work. The same applies to pharmacist Dr. Usfeya
Muazzam who acts for the Bundesinstitut für Arzneimittel und Medizinprodukte
(BfArM) (Federal Institute for Drugs and Medicinal Products) within the
department.
Event on REACH on 12 October 2006 The symposium on the subject "REACH" organized by the department
is the scheduled to take place in Berlin on 12 October 2006 and will be
organized in cooperation with the BfR. In the scope of the event, suggestions
on the practical realization of the REACH implementation will be presented
from a scientific view. |
|||||||
February 2008 | Copyright © 2000 - 2014 Institute for Dermopharmacy GmbH. Contact: webmaster@gd-online.de |